Literature DB >> 7494492

Further characterization of Chlamydia pneumoniae specific monoclonal antibodies.

M Puolakkainen1, J Parker, C C Kuo, J T Grayston, L A Campbell.   

Abstract

Studies using monoclonal antibodies have demonstrated species-specific reactivities with Chlamydia pneumoniae. In this study, further characterization of C. pneumoniae specific monoclonal antibodies TT-205 and RR-402 and description of C. pneumoniae specific antibodies prepared against other isolates are presented. TT-205 and RR-402 were shown to neutralize infectivity. Neutralization in cell culture was specific and enhanced by complement. Attempts to characterize the reactive antigen by immunoblotting, immunoaffinity chromatography and radioimmunoprecipitation were unsuccessful, probably due to difficulties in solubilizing the immunoreactive epitope without denaturing it. Recognition of the determinant by the monoclonal antibodies is labile to physical and chemical treatments suggesting that the reactive epitope is conformational.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494492     DOI: 10.1111/j.1348-0421.1995.tb02241.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods.

Authors:  A Meijer; P J Roholl; S K Gielis-Proper; Y F Meulenberg; J M Ossewaarde
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

2.  Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients.

Authors:  J Gieffers; E Reusche; W Solbach; M Maass
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Authors:  Claudio Cortes; V P Ferreira; Michael K Pangburn
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

4.  Molecular evidence for association of chlamydiales bacteria with epitheliocystis in leafy seadragon (Phycodurus eques), silver perch (Bidyanus bidyanus), and barramundi (Lates calcarifer).

Authors:  Adam Meijer; Paul J M Roholl; Jacobus M Ossewaarde; Brian Jones; Barbara F Nowak
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

5.  Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases.

Authors:  Claudio Cortes; Kimberly A Rzomp; Amy Tvinnereim; Marci A Scidmore; Benjamin Wizel
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

6.  Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Authors:  K Knudsen; A S Madsen; P Mygind; G Christiansen; S Birkelund
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells.

Authors:  C Kuo; N Takahashi; A F Swanson; Y Ozeki; S Hakomori
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

8.  Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants.

Authors:  K Wolf; E Fischer; D Mead; G Zhong; R Peeling; B Whitmire; H D Caldwell
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions.

Authors:  A Meijer; P J Roholl; S K Gielis-Proper; J M Ossewaarde
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

10.  Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Hans F Berg; Boulos Maraha; Anneke van der Zee; Siska K Gielis; Paul J M Roholl; Gert-Jan Scheffer; Marcel F Peeters; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.